These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1956910)

  • 1. Human cytochromes P450: evolution, catalytic activities and interindividual variations in expression.
    Gonzalez FJ; Gelboin HV
    Prog Clin Biol Res; 1991; 372():11-20. PubMed ID: 1956910
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphic oxidation of debrisoquine and sparteine.
    Eichelbaum M
    Prog Clin Biol Res; 1986; 214():157-67. PubMed ID: 3523506
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular genetics of the debrisoquin-sparteine polymorphism.
    Gonzalez FJ; Meyer UA
    Clin Pharmacol Ther; 1991 Sep; 50(3):233-8. PubMed ID: 1680592
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic polymorphisms of drug metabolism.
    Meyer UA; Zanger UM; Skoda RC; Grant D; Blum M
    Prog Liver Dis; 1990; 9():307-23. PubMed ID: 2156298
    [No Abstract]   [Full Text] [Related]  

  • 5. [The diversity of hepatic p-450 cytochromes: their role in chemical carcinogenesis].
    Anderson A; Waithe W; Labbé D; Affolter M; Labelle Y
    Union Med Can; 1985 Sep; 114(9):731-2. PubMed ID: 4060344
    [No Abstract]   [Full Text] [Related]  

  • 6. [Genetic polymorphism of oxidative drug metabolism. Therapeutic and toxicologic implications].
    Eichelbaum M
    Internist (Berl); 1983 Mar; 24(3):117-27. PubMed ID: 6135670
    [No Abstract]   [Full Text] [Related]  

  • 7. Polymorphic drug oxidation in humans.
    Eichelbaum M
    Fed Proc; 1984 May; 43(8):2298-302. PubMed ID: 6714436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baculovirus expression of human P450 2E1 and cytochrome b5: spectral and catalytic properties and effect of b5 on the stoichiometry of P450 2E1-catalyzed reactions.
    Patten CJ; Koch P
    Arch Biochem Biophys; 1995 Mar; 317(2):504-13. PubMed ID: 7893169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical aspects of the polymorphism of oxidation phenotype].
    Mrozikiewicz PM
    Pol Tyg Lek; 1992 Jul 6-13; 47(27-28):608-10. PubMed ID: 1488339
    [No Abstract]   [Full Text] [Related]  

  • 10. Gas chromatography/mass spectrometry assays for the determination of debrisoquine and sparteine metabolites in microsomal fractions of rat liver.
    Ho JW; Moody DE
    Anal Biochem; 1992 Jun; 203(2):348-51. PubMed ID: 1416032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of genetic polymorphism in psychopharmacology--an update.
    Brøsen K; Sindrup SH; Skjelbo E; Nielsen KK; Gram LF
    Psychopharmacol Ser; 1993; 10():199-211. PubMed ID: 8361977
    [No Abstract]   [Full Text] [Related]  

  • 12. Construction of a human cytochrome P450 1A1: rat NADPH-cytochrome P450 reductase fusion protein cDNA and expression in Escherichia coli, purification, and catalytic properties of the enzyme in bacterial cells and after purification.
    Chun YJ; Shimada T; Guengerich FP
    Arch Biochem Biophys; 1996 Jun; 330(1):48-58. PubMed ID: 8651703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of cytochrome P450 gene superfamily for the clinical pharmacokinetics of drugs].
    Brøsen K
    Ugeskr Laeger; 1991 Feb; 153(6):417-22. PubMed ID: 2000644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some aspects of interindividual variations in the metabolism of xenobiotics.
    Tamási V; Vereczkey L; Falus A; Monostory K
    Inflamm Res; 2003 Aug; 52(8):322-33. PubMed ID: 14504670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins.
    Gonzalez FJ; Gelboin HV
    Drug Metab Rev; 1994; 26(1-2):165-83. PubMed ID: 8082563
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationship between imipramine metabolism and the sparteine oxidation polymorphism.
    Brøsen K
    Dan Med Bull; 1988 Oct; 35(5):460-8. PubMed ID: 3066590
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity.
    Wan J; Imaoka S; Chow T; Hiroi T; Yabusaki Y; Funae Y
    Arch Biochem Biophys; 1997 Dec; 348(2):383-90. PubMed ID: 9434752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of xenobiotics and chemical carcinogenesis.
    Lang M; Pelkonen O
    IARC Sci Publ; 1999; (148):13-22. PubMed ID: 10493245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conserved proline-rich sequence between the N-terminal signal-anchor and catalytic domains is required for assembly of functional cytochrome P450 2C2.
    Chen CD; Doray B; Kemper B
    Arch Biochem Biophys; 1998 Feb; 350(2):233-8. PubMed ID: 9473296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
    Raza H; King RS; Squires RB; Guengerich FP; Miller DW; Freeman JP; Lang NP; Kadlubar FF
    Drug Metab Dispos; 1996 Apr; 24(4):395-400. PubMed ID: 8801053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.